DRREDDY's weekly performance was relatively stable, with a return of 0.3%, outperforming peers DIVISLAB and SUNPHARMA, but underperforming HINDUNILVR. The stock's volatility was moderate at 17.33%, similar to SUNPHARMA's level. Despite a low Sharpe Ratio of 0.07, the stock's Max Drawdown was contained at -1.25%, indicating a relatively low-risk profile for the week.

[Volatility: 17.33%]